<DOC>
	<DOC>NCT00694343</DOC>
	<brief_summary>The aim of the study is to evaluate the efficacy of Voluven® in the prevention of maternal hypotension in women undergoing spinal anesthesia for cesarean section</brief_summary>
	<brief_title>Efficacy of Voluven® for the Prevention of Hypotension During Spinal Anesthesia for Cesarean Section</brief_title>
	<detailed_description>Intravenous fluid administration prior to spinal anesthesia for cesarean section is an established part of anesthetic practice for the prevention of maternal hypotension. Systematic reviews of clinical data suggest the usefulness of administering colloids to decrease the incidence of hypotension This study will compare the clinical efficacy and safety of HES 130/0.4 (6%) in normal saline vs. Ringer's lactate solution in prevention of hypotension during spinal anesthesia for elective cesarean section.</detailed_description>
	<mesh_term>Hypotension</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<criteria>elective cesarean section applying spinal anesthesia ≥ week 37 of gestation Singleton pregnancy Suspicion of any hypertensive disease Parturient in labor</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Cesarean section</keyword>
	<keyword>spinal anesthesia</keyword>
	<keyword>hypotension</keyword>
</DOC>